![](https://investorshub.advfn.com/uicon/40536.png?cb=1561902029)
Monday, July 15, 2019 5:22:59 PM
We will see who is right when the year plays out and we see the increasing revs, more and more patient testimonials and the trial paper is issued. I have seen nothing that suggest CELZ is doing anything wrong or lying about anything. I hope those trying to make a case call the SEC and get there satisfaction. Maybe they have the fortitude to post when the SEC finds nothing wrong!!!
Some employees have come and some have gone from the company, same as every company. What’s the hang up with that I do not know. I know my company hires and fires everyday with no press releases.
As for the poster who had the treatment. First, NO ONE ever said CaverStem works 100%, 100% of the time. Dr. Said has posted that he has seen improvement in all of his patients so far. That is super cool to see, but it is a small sample size, correct? Probably getting near 75-100 patients is my guess, but let’s see how it plays out. I imagine that a 55 year old having some early stage issues has a very high success rate vs someone who has highly risky behaviors and continues those behaviors after treatment. But who knows? Not me for sure. I hope all patients find some form of improvement no matter what hit them where they are!!!!
Why get hung up on one person who did not find the fix for them? Does that make the entire company a scam?? Of course not. It’s the percentage of patients, rightly or wrongly, that fall into that small percentage of patients that do not react to treatment, period. Pretty simple really.
Let’s not let shareholder frustration in the PPS get in the way of thinking the treatment does not work or is the entire company is a scam. At least I know the CEO preferred shares vs CASH. Pretty cool if you ask me.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM